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Abstract
Background: MicroRNAs (miRNAs) are small RNAs that recognize and regulate mRNA target genes. Multiple lines of
evidence indicate that they are key regulators of numerous critical functions in development and disease, including cancer.
However, defining the place and function of miRNAs in complex regulatory networks is not straightforward. Systems
approaches, like the inference of a module network from expression data, can help to achieve this goal.
Methodology/Principal Findings: During the last decade, much progress has been made in the development of robust and
powerful module network inference algorithms. In this study, we analyze and assess experimentally a module network
inferred from both miRNA and mRNA expression data, using our recently developed module network inference algorithm
based on probabilistic optimization techniques. We show that several miRNAs are predicted as statistically significant
regulators for various modules of tightly co-expressed genes. A detailed analysis of three of those modules demonstrates
that the specific assignment of miRNAs is functionally coherent and supported by literature. We further designed a set of
experiments to test the assignment of miR-200a as the top regulator of a small module of nine genes. The results strongly
suggest that miR-200a is regulating the module genes via the transcription factor ZEB1. Interestingly, this module is most
likely involved in epithelial homeostasis and its dysregulation might contribute to the malignant process in cancer cells.
Conclusions/Significance: Our results show that a robust module network analysis of expression data can provide novel
insights of miRNA function in important cellular processes. Such a computational approach, starting from expression data
alone, can be helpful in the process of identifying the function of miRNAs by suggesting modules of co-expressed genes in
which they play a regulatory role. As shown in this study, those modules can then be tested experimentally to further
investigate and refine the function of the miRNA in the regulatory network.
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Introduction
MicroRNAs (miRNAs) are small endogenous regulatory
RNAs, present in a wide variety of eukaryotic organisms. They
are incorporated into an RNA induced silencing complex (RISC)
that binds to sites of variable complementarity in target
messenger RNAs, triggering their degradation and/or repressing
their translation [1]. Evidence for the participation of miRNAs in
cell growth, cell differentiation and cancer is currently piling up.
Nearly half of the annotated human miRNAs map within fragile
chromosomal regions, which are areas associated with various
types of human cancers. Recent evidence indicates that miRNAs
as well as the factors that participate in miRNA biogenesis may
function as tumor suppressors and/or oncogenes [2]. According
to the latest miRBase repository release [3], there are .700
human mature miRNA sequences identified with experimental
support, while some computational studies expand this list to
more than 1,000 [3], roughly equaling the number of
transcription factors [4]. Computational and experimental studies
have also predicted that between 30% and 100% of the human
protein coding genes might be under the post-transcriptional
regulation of miRNAs [5,6]. It is not difficult to see that even by
taking the most conservative values, the regulatory network
induced by such a large number of regulators and targets is
potentially extremely large. Furthermore, miRNAs do not act in
isolation, but are part of a complex regulatory network, involving
transcription factors, signal transducers and other types of
regulatory molecules [7]. Reconstructing and analyzing such
regulatory networks is thus a complex but crucial challenge to
tackle.
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Various algorithms exist to infer regulatory networks from
expression data [8,9,10]. One of the most powerful methods,
especially for eukaryotic organisms, assumes a modular structure
of the underlying regulatory network, where a group of co-
expressed genes is regulated by a common set of regulators (also
known as the regulatory program) [10]. The regulatory program
uses the expression levels of the set of regulators to predict the
condition-dependent mean expression of the co-expressed genes.
Thus, modules are composed of clusters of co-expressed genes
together with their associated regulators. As a regulator can be
associated with more than one module, the ensemble forms a
module network. We have recently developed a novel algorithm
which extends the original module network concept of Segal and
co-workers [10] by using probabilistic optimization techniques
which enable prioritization of the statistically most significant
clusters of co-expressed genes and their candidate regulators
[11,12]. The main advantage of this algorithm is that it extracts
more representative centroid-like solutions from an ensemble of
possible statistical models, in order to avoid suboptimal solutions.
By testing it on various biological datasets, we have shown that this
approach generates more coherent modules, and that regulators
consistently assigned to a module are more often supported by
external sources of data [11,12].
In this study, we have adapted our module network algorithm to
take as input a heterogeneous dataset of both miRNA and
messenger RNA (mRNA) expression data measured on the same
samples. Multiple miRNAs are assigned as high-scoring candidate
regulators for several modules, together with well-known tran-
scription factors or signal transducers. A detailed analysis of three
modules where miRNAs are selected as high-scoring regulators
shows that this assignment is highly coherent with the module
function and is also supported by various external sources of data.
We have also validated one of those modules experimentally,
showing that over-expression or inhibition of the miRNA assigned
as a regulator changes significantly the expression of a selection of
module genes, thereby confirming the inference of the algorithm.
Those results corroborate module network inference as a robust
and useful approach to gain more precise insights into miRNA
function.
Results
Inference of a microRNA module network from
expression data
The LeMoNe algorithm, starting from an expression data
matrix and a list of candidate regulators, will produce a module
network, composed of modules of co-expressed genes and their
associated regulators. The algorithm is also clustering the
conditions (columns) for each set of co-expressed genes, creating
condition clusters. The list of regulators for a given module is
ordered according to their individual score. This score only takes
into account the differential expression of the regulator across the
different different condition clusters, and not their absolute value.
This way we can simultaneously evaluate and compare mRNA
and miRNA candidate regulators, using the expression levels of
each class of regulators. As input for our algorithm, we used a
dataset composed of expression data measured on 89 tumor and
normal tissue samples (representing 11 tumor classes) both for
11,833 messenger RNAs and 124 miRNAs [13]. Unlike previous
attempts [14,15,16], our approach for the integration of miRNAs
in the network is not based on miRNA target prediction, or a
mixture between target prediction and expression data, but relies
solely on expression data. The algorithm generated a set of 76
tightly co-expressed gene clusters, corresponding to a total of 2,987
genes. We calculated the GO enrichment for all the modules [17]
and found a total of 44 clusters having at least one GO category
enriched (p,0.05), for a total of 589 enriched categories (the
complete list of modules and their GO categories is available as
table S2). For the assignment of regulators, we compiled a list of
1,841 candidate regulators based on their GO annotation (either
transcription factors or signal transducers), plus the list of 124
miRNAs. After the assignment of regulators we took a stringent
cutoff corresponding to the top 2% most significant predicted
regulatory interactions (Figure 1), obtaining a final set of 294
unique regulators (the complete list of module genes and regulators
is available in table S1). Within this set, ten miRNAs were selected
as regulators for a total of seven modules (Table 1). In order to
assess the validity and the relevance of the inferred module
network, we here present a detailed analysis of three modules, with
an emphasis on the typical features of miRNA mediated
regulatory modules. Those modules were selected based on their
intrinsic interest, functional coherence and the high number of
literature references discussing their putative function.
MiR-133 and miR-145 are assigned as regulators of a
smooth muscle actomyosin module
Module 29 is a small module composed of four genes and five
assigned regulators (Figure 2a). The GO over-represented
categories for this module are linked to smooth muscle
development and actomyosin structure (Figure 2a and table S2).
MYH11 encodes a smooth muscle myosin heavy chain family
member. ACTG2 is a gamma 2 actin protein found in enteric
tissues. The two other genes in the module (MYLK and CNN1)
are well known regulators of the actin-myosin interactions. MYLK
is the myosin light chain kinase, a dedicated calcium-dependent
kinase that phosphorylates a specific site on the regulatory light
chain of the myosin, enhancing its activity. MYLK is ubiquitous in
all adult tissues with the highest amounts found in smooth muscle
tissues [18]. CNN1 (calponin) is a calcium binding protein that
inhibits the ATPase activity of the myosin in smooth muscle. The
top regulator (PPP1R12B) selected for this module is a myosin
phosphatase subunit. The myosin phosphatase is also a well known
core regulator of the actomyosin pathway, inhibiting the myosin
activity [18]. The second high scoring candidate regulator is a
miRNA, miR-133, while the third regulator is the TGF-beta
stimulated clone-22 member 1 (TSC22D1) gene, which encodes a
leucine zipper domain protein, a member of the TGF-beta1
pathway which is involved in the regulation of transcription. The
last regulators are ANGPTL2, a vascular endothelial growth
factor, and another miRNA, miR-145.
The two miRNAs selected as regulators for this module clearly
show a tightly positively correlated expression pattern with the
module genes (Figure 2a). As most miRNAs have been
characterized so far as negative regulators of gene expression, this
suggest an indirect regulation between the miRNAs and module
29 genes. Recent studies reveal several likely candidate genes that
could act as intermediate regulators between the miRNAs and
module 29 genes. MiR-133, selected as the second best regulator
for this module (Figure 2a), was recently shown to be a key
regulator for skeletal muscle development and cardiac muscle
hypertrophy [19,20]. In those studies, miR-133 has been shown to
directly regulate the SRF transcription factor. SRF is recognized
as a vital factor for normal cytoskeletal and contractile cell
activities and all the module 29 genes (MYH11, CNN1, ACTG2,
MYLK) are known to be direct targets of SRF [21]. Those
literature results support the hypothesis of an indirect regulatory
link between miR-133a and module 29 genes via SRF. Most
studies on SRF activity have so far characterized this factor as a
A MicroRNA Module Network
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transcriptional activator [21], but some results also suggest that
SRF might act as a transcriptional repressor of its targets genes
[22,23,24]. SRF mediated gene repression is not clear, but it might
involve the recruitment by SRF of transcriptional silencers [23,24].
If we hypothesize that SRF is repressing the transcription of
module 29 genes, then the regulatory chain miR-133 – SRF –
module 29 genes can explain the positive gene expression
correlation that is observed in Figure 2a. The other miRNA
selected as a regulator, miR-145 was recently shown to be an
important regulator for smooth muscle cell fate [25]. This study
[25] also shows that miR-145 is activating one of its direct targets,
the myocardin (Myocd), which is a transcription factor well known
to activate smooth muscle gene expression by interacting with SRF
[26]. Thus we also have a regulatory chain miR-145 – Myocd –
module 29 genes that can explain the pattern of expression
observed in Figure 2a. Neither SRF nor Myocd are assigned as
regulators or clustered together with the other module 29 genes.
Unfortunately, the myocardin gene was not present in the
microarrays used to produce the datasets [13]. The profile of the
SRF transcription factor appears to correlate poorly with the
expression of module 29 genes in our dataset (Data file S1),
explaining why this gene could not be selected as a regulator.
Several reasons could explain why the profile is divergent, like
post-translational modifications or the fact that miRNAs act at the
post-transcriptional level, possibly preventing the regulatory effect
to be detected (by repressing the translation).
MiR-142s are assigned as regulators of an immune
response module
Module 18 is composed of six genes (Figure 2b), of which five
encode immunoglobulins corresponding either to the heavy chain
(IGHG4, IGHA2, IGHA1) or to the light chain (IGKV1-5,
IGLV3-21), while IGLL1 is the surrogate light chain, a critical
component of the pre-B cell receptor complex. Not surprisingly,
we found the GO category immune response over-represented for
this module (Figure 2b and table S2). All the module genes are
known to be mostly expressed in developing and mature B-cells,
revealing a coherent module [27]. Nine high scoring regulators
were selected for this module. The top regulator is a homeobox
gene, HOXC5. The HMGA1 gene is selected as the second best
regulator for this module. High mobility group proteins (HMGA)
regulate the activity of a wide variety of genes by changing the
DNA conformation of their target genes. HMGA1 is known to co-
activate transcription in B-cells and to be important for B-cells
development [28]. The third and fourth candidate regulators are
two miRNAs processed from the same precursor, miR-142-5p and
miR-142-3p. The HLA-DRB1 gene belongs to the HLA class II
beta chain paralogues. It is known to play a central role in the
immune system by presenting peptides derived from extracellular
proteins [29]. CCL5 is a chemotactic cytokine playing an active
role in recruiting leukocytes to inflammatory sites [30]. AXL is a
receptor tyrosine kinase that is transforming in fibroblast and
hematopoietic cells, and is involved in mesenchymal development
[31]. CXCL14 is a small cytokine belonging to the CXC
chemokine family. This gene is chemotactic for monocytes and
can activate these cells in the presence of an inflammatory
mediator [32]. CXCL14 expression is reduced or absent from
most cancer cells [33]. This module is probably linked to an
immune response triggered by various tumor states. Such
persistent pro-tumor immune responses are known to potentiate
primary tumor development and malignant progression.
MiR-142s are preferentially expressed in hematopoietic tissues
and their expression is regulated during hematopoiesis, suggesting
a role in immune cells differentiation [34]. The transcription factor
Figure 1. Random and real regulators score distributions. The histograms represent the distribution of randomly assigned (green) and true
(yellow) regulators scores for the module network. The arrow for the random regulators represents the maximum score for randomly assigned
regulators with the value indicated between brackets. The arrow for the true regulators represents the cutoff score value, with the raw value
indicated between brackets.
doi:10.1371/journal.pone.0010162.g001
A MicroRNA Module Network
PLoS ONE | www.plosone.org 3 April 2010 | Volume 5 | Issue 4 | e10162
Table 1. List of modules where miRNAs have been selected as high-scoring regulators.
Module ID
Number of genes
in the module
GO categories enriched for
the module (p,0.05) Regulators Score
15 73 None MAFB 3065
NFIB 2774
MSRB2 713
IGFALS 464
NR2C1 457
CCL23 392
MORF4L1 288
FOS 249
let-7c 231
miR-125b 209
17 17 Digestion NFIB 3785
Proteolysis HEYL 2361
Lipid catabolic process PLA2G1B 2164
miR-216 1085
CCRL2 780
MC5R 327
TRAF1 285
CDX1 261
DLX2 254
E2F1 251
IFNGR1 250
CCR9 244
TACR3 215
18 6 Immune response HOXC5 1937
HMGA1 1007
miR-142-5p 863
miR-142-3p 709
HLA-DRB1 380
CCL5 241
AXL 215
CXCL14 214
25 9 None miR-200a 1786
PPP1R1B 727
GPR30 512
PTGER3 456
ZNF157 320
GNB3 262
GNG5 209
29 4 Actomyosin structure organization and biogenesis PPP1R12B 7346
Smooth muscle contraction miR-133a 1216
Smooth muscle fiber development TSC22D1 1209
Elastic fiber assembly ANGPTL2 353
Striated muscle development miR-145 220
35 20 None NFATC1 2827
SH3BP1 2162
FMNL2 699
RASSF4 381
GNAQ 290
A MicroRNA Module Network
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TCF12 is predicted as a target for miR-142-3p [35]. In a previous
study, a combined dosage of the factors E2A, E2-2 and TCF12
was shown to be required for normal B-cell development. More
precisely, TCF12 is important for the generation of normal
numbers of pro-B-cells [36]. Because module 18 genes are
expressed in developing B-cells, the regulation of TCF12 by
miR-142-3p might be important for this process. Furthermore, we
found conserved binding motifs for TCF12 for most module 18
genes (Data file S1), indicating that this transcription factor could
be important for their regulation. Like for module 29 and SRF, the
expression profile of TCF12 is highly divergent from the
expression profiles of module 18 genes, explaining why this gene
was not selected as module gene or regulator (data not shown).
Mir-200a is a key regulator of a module involved in
epithelial homeostasis
Module 25 is composed of nine genes (Figure 2c). SCNN1A
(also known as ENaC) is the subunit alpha of the amiloride
sensitive epithelial sodium channel, expressed in many epithelial
tissues [37]. PRSS8 (prostasin) is a trypsinogen which regulates the
activity of the epithelial sodium channel [38]. FDXY3 is a small
membrane protein that is highly transcribed in tissues such as
uterus, stomach and colon, and may function as a Na/K channel
regulator [39]. TACSTD1, the tumor-associated calcium signal
transducer 1, functions as a calcium-independent cell adhesion
molecule [40]. Other genes like ATAD4 or TMEM63A are trans-
membrane proteins of unknown function. RAB25 is a small GTP
binding protein. RAB proteins have been involved in the
regulation of vesicle trafficking [41]. The module top regulator is
miR-200a. Regarding the other regulators, PPP1R1B is a
phosphoprotein regulated by dopamine and cAMP, and is an
inhibitor of the protein phosphatase 1. Besides its well-known role
in the central nervous system, it is highly expressed in a variety of
epithelial tissues where it might play a role in epithelial signaling
and tumorigenesis [42]. GPR30 is a trans-membrane G protein
coupled estrogen receptor [43], while PTGER3 is a G-protein
coupled prostaglandin E2 receptor that is involved in various
physiological processes and was shown to affect intracellular
concentrations of Ca++ and cAMP [43]. ZNF157 is a zinc finger
protein of unknown function while GNB3 and GNG5 are G
proteins subunits involved in signal transduction. From the
functions of these genes, we can conclude that most of the module
25 genes and regulators are likely involved in epithelial
homeostasis, although we did not find any particular GO category
enriched for this module. It is also worth noting that several of
those genes are related to tumor progression [40,41,44].
MiR-200a, which was selected as the best candidate regulator
for module 25, is a member of a miRNA family of five closely
related miRNAs (miR-200a, miR-200b, miR-200c, miR-141 and
miR-429). Recent publications show epithelial-specific expression
of miR-200a and miR-200b [45,46]. We designed a set of
experiments to validate the role of miR-200a as a regulator of the
expression of genes in module 25. MiR-200a was introduced in a
human de-differentiated epithelial breast cancer cell line MDA-
MB-231, known to express aberrantly low levels of miR-200a. The
expression of six genes (RAB25, IRF6, SCNN1A, PRSS8, ATAD4,
TACSTD1) out of nine belonging to module 25 was monitored
using RT-qPCR (Figure 3). Without exception, the six monitored
genes show a clear up-regulation upon exogenous expression of
miR-200a (Figure 3a). The reverse experiment, inhibition of some
members of the miR-200 family (miR-200a,b,c) in the MDA-MB-
231 cells using antagomirs, resulted in the significant down-
regulation of four out of five tested genes, (SCNN1A is not
significantly down-regulated, ATAD4 is not expressed in normal
conditions in this cell line)(Figure 3b). Those results clearly show
that miR-200a is a core regulator of module 25, most probably
with other members of the miR-200 family.
In this module, we observe again a clear positive correlation
pattern between miR-200a and the module genes expression,
suggesting an indirect regulatory circuit between miR-200a and
module 25 genes (Figure 2c and Figure 3a and 3b). Recent
experimental work showed that miR-200 family members directly
target the transcription factors ZEB1 and ZEB2 [47,48,49].
These transcription factors are known as major transcriptional
repressors of epithelial differentiation orchestrating epithelial
mesenchymal transition (EMT) [50]. EMT is a process that drives
epithelial cells from a polarized phenotype to a highly motile, non
polarized mesenchymal phenotype and is known to occur in
epithelial tumors giving rise to highly malignant cancer cells. The
ZEB transcription factors have been functionally related to
members of the miR-200 family via a double negative feedback
loop, thus promoting EMT and cancer invasion [47,51,52]. We
found conserved ZEB binding motifs for several module 25 genes
(Data file S1), suggesting that ZEB factors could be the
intermediate regulators between miR-200 and module 25 genes.
To test this hypothesis, we down-regulated the ZEB1 transcrip-
tion factor in MDA-MD-231 cells with a specific siRNA while
monitoring the expression of eight module 25 genes (Figure 3c).
All the genes show a strong up-regulation pattern, with the
exception of the gene RAB25 (Figure 3c). Those results
demonstrate that the ZEB1 factor is essential for the regulation
of module 25 genes. Taken together, our experimental results
(Figure 3) strongly suggest the existence of a regulatory chain
between miR-200 and module 25 genes via the ZEB1
transcription factor (Figure 4). As both miR-200 and ZEB1 play
important roles in EMT [47,48,49,51,52] we hypothesize that
module 25 repression might contribute to the malignant EMT
process in cancer cells.
Module ID
Number of genes
in the module
GO categories enriched for
the module (p,0.05) Regulators Score
CTNNBIP1 288
miR-181* 249
94 3 Folic acid metabolic process miR-10a 253
Regulation of Notch signaling pathway
Folic acid transport
All regulators that are above cutoff are listed for each module, and ordered according to their decreasing score value. MicroRNA genes are highlighted in bold.
doi:10.1371/journal.pone.0010162.t001
Table 1. Cont.
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Figure 2. Modules 29 (a), 18 (b) and 25 (c) genes (MG) and assigned regulators (MR). Gene expression values are color coded, ranging from
dark blue (low expression levels) to bright yellow (high expression levels). In each figure, columns represent a different sample. The color-coded bar
at the bottom of the graph represents the tissue origin (see the legend), while the gray squares just below indicate whether the sample tissue was
normal (light gray) or tumor (dark gray). The candidate regulators are ordered by decreasing score value (from top to bottom). The samples are
A MicroRNA Module Network
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Discussion
MiRNAs have emerged quite recently as a new and important
layer of regulation. Most of the studies so far have focused on their
identification and on the detection of their targets. Several
experimental studies have shown that at least some of them play
key roles in various developmental and cellular pathways.
Integrating miRNAs in regulatory networks is therefore of
fundamental importance and should ideally be done taking into
account the other types of regulatory molecules. So far, a few studies
have proposed a computational strategy to infer miRNA mediated
module networks [14,15,16]. These were mainly based on miRNA
target prediction, or on a combination of target prediction and
expression data. We have applied a robust and unbiased module
network inference algorithm to a cancer-related expression data set
of both mRNAs and miRNAs. In our approach, miRNAs were
considered as candidate regulators, together with other types of
regulators, like transcription factors and signal transducers. Even
after applying a stringent cutoff, several miRNAs were retained as
high scoring, statistically significant candidate regulators for various
modules. Through an in-depth analysis of three of those modules,
we showed that the assignment of specific miRNAs as regulators is
supported by various external sources and is functionally coherent.
Furthermore, we could show experimentally that a miRNA,
assigned as the best regulator, is indeed a key regulator for the
module genes expression. The number of miRNAs assigned in this
study (10) might seem rather modest, but this number has to be
evaluated with respect to the total number of miRNAs for which
expression was measured in the samples (124). The ratio assigned
per total number of miRNAs is equal to 8%, while the same ratio
value is 15% for the ensemble transcription factors plus signal
transducers (284/1841). The two ratio values are comparable and
therefore we can reasonably expect a higher number of miRNAs
assigned when an increased coverage of the miRNome expression
landscape will be available.
Nevertheless, just as with other similar methods, care has to be
taken for the interpretation of the inferred regulatory model. In
particular, correlation of gene expression might not always indicate
a direct interaction. Indeed, for the three modules we have
investigated in detail, we have found an indirect regulation pathway
between the regulator and the module genes. Furthermore, none of
those indirect regulator genes were assigned by the algorithm in the
regulation program or even clustered together with the module
genes. As we could show for module 29 and the SRF transcription
factor, the reason is because those indirect regulators expression
profile differ significantly from those of the module genes. Various
reasons can explain this divergence, for example the regulation
might happen at the post-transcriptional level, or might be the result
of post-translational modifications. Indirect regulators might of
course complicate the interpretation of the results but they are to be
expected, especially in higher eukaryotic organisms where regula-
tory networks are expected to be more complex [53].
Taken together, our results show that novel insights can be gained
from a robust module network analysis of miRNA and mRNA
expression data and support the view that at least some miRNAs
have key regulatory roles in important cellular processes. Our
approach has also the advantage of providing a direct view of post-
transcriptional modifications through the integration of miRNAs,
where mRNA expression alone might not be enough to reveal the
existence of regulatory interactions. All three modules for which we
did a detailed analysis in this study have each a coherent set of
genes, involved in the same process and function. Furthermore, by
connecting miRNAs to coherent modules, we believe that this
approach can help to elucidate miRNA function and could
efficiently drive experimental work towards the identification of
key regulatory components in various processes. With the rapid
proliferation of various techniques to measure with a high accuracy
the levels of expression for hundreds of miRNAs, and the
concomitant availability of mRNA expression data, it will be highly
appealing to apply computational strategies like the one we describe
here to expand our knowledge on global regulatory networks.
Materials and Methods
Expression data sets
We used a normalized cancer expression data set previously
published [13]. We performed additional filtering steps to improve
the quality of the input data set. Probesets with no known ensembl
gene identifiers were discarded, as well as miRNA sequences that
were not annotated as human miRNAs in the most recent
miRBase release [3]. The final data matrix contained 11,833 genes
and 124 miRNAs, for which expression was measured across 89
samples covering 11 different tumor classes.
Module network inference
We used the LeMoNe algorithm to infer the module network
[11,12,54]. In a first step, the algorithm is searching for a partition
of genes into clusters of co-expressed genes. In a second step, the
algorithm defines a regulatory program (a set of regulator genes)
for each cluster. To avoid local optima traps in the first step, the
algorithm uses a gibbs sampling approach for two-way clustering
of both genes and conditions [54]. For a given input expression
matrix, multiple clustering solutions are generated. For this study,
we generated 30 different cluster solutions from the initial dataset.
This ensemble of partially overlapping solutions is averaged to
produce a set of tight clusters, representing subsets of genes which
consistently cluster together in all solutions. The set of tight clusters
is extracted using a graph spectral method [54]. For the second
step, regulation programs are learned using a fuzzy decision tree
model. The two-way clustering of the first step has also generated
condition clusters (set of conditions having a similar mean and
standard deviation) for each set of co-expressed genes. The
condition clusters of a given module are first linked together in a
hierarchical decision tree. Each node in the tree is defining a split
between two sets of conditions (corresponding to low and high
expression levels). Regulators are assigned to each node of the tree
using a probabilistic score reflecting how well the expression levels
of the regulator match the genes expression levels defined by the
split value (for details about the mathematical model of the
algorithm, see [11]). Just as for the gene clusters, multiple solutions
are generated for the conditions clusters. Consequently, there are
multiple decision trees and multiple regulators assigned for each
node of each hierarchical tree. We adopt an ensemble approach
again by summing the strength with which a regulator participates
in each regulatory program for a given set of co-expressed genes. A
global score is calculated, reflecting the statistical confidence of the
regulator over all the nodes of all the hierarchical trees generated
for the set of co-expressed genes [11]. For this study, we assigned
up to 100 regulators for each node of each of the 100 hierarchical
trees defined for each module. It is worth noting that by using a
grouped in leaves of homogeneous expression values, according to the hierarchical trees indicated on top of each figure. The orange boxes at the
right of the figure indicate overrepresented GO categories (p#0.05).
doi:10.1371/journal.pone.0010162.g002
A MicroRNA Module Network
PLoS ONE | www.plosone.org 7 April 2010 | Volume 5 | Issue 4 | e10162
score that only takes into account the differential expression of a
regulator across the different condition clusters, we can simulta-
neously evaluate and compare mRNA and miRNA candidate
regulators. In the end, the set of regulators assigned to each cluster
of co-expressed genes can be ranked according to their global
probabilistic score and a cutoff level can be defined, keeping only
very high-scoring regulators. In order to evaluate the statistical
significance of the assigned regulators, a second set of randomly
assigned regulators is generated along the set of ‘‘true’’ regulators
(Figure 1). The complete list of modules together with their high-
scoring regulators for this study is available in the table S1. The
LeMoNe software package can be downloaded from our website,
is open-source and free of charge for academics (http://
bioinformatics.psb.ugent.be/software/details/lemone).
Figure 3. Validation of miR-200a as a regulator of module 25 genes expression. (a) Real time quantitative PCR (RT qPCR) analysis of the
expression of module 25 genes RAB25, IRF6, SCNN1A, PRSS8, ATAD4 and TACSTD1 and upon over-expression of miR-200a in MDA-MD-231 cells (mean
6 standard deviation). The y-axis represents the relative mRNA expression value. miR-1 was used as the control (Ctrl), as it is not known to target any
of the monitored genes (b) RT qPCR analysis of the relative expression for the genes RAB25, IRF6, SCNN1A, PRSS8 and TACSTD1 in MDA-MB-231 cells
infiltrated with miR-200a,b,c antagomirs. The y-axis represents the relative mRNA expression value (mean 6 standard deviation). miR-1 was used as
the control (Ctrl) (c) RT qPCR analysis of the relative expression levels of module 25 genes RAB25, IRF6, SCNN1A, PRSS8, ATAD4, TACSTD1, TMEM63A
and FXYD3 in MDA-MB-231 cells where ZEB1 is knocked down. The first barplot (black) shows effective repression of ZEB1 levels upon transfection
with the ZEB1 specific siRNA. Par = parental cell culture, Mock = mock transfection, si-ZEB1 = transfection with the ZEB1 specific siRNA.
doi:10.1371/journal.pone.0010162.g003
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Gene Ontology over-represented categories
For each module, we calculated GO enrichment using the
BiNGO tool [17]. The complete list of GO categories enrichment
for all the modules is available in the table S2.
Transcription factor binding motifs
We used the ConTra [55] software tool to look for conserved
TCF12 and ZEB motif binding sites in the promoter regions of
module 18 and 25 genes. A multiple alignment of nine eutherian
mammal species (Bos taurus, Canis familiaris, Equus caballus, Pan
troglodytes, Pongo pygmaeus, Macacca mulatta, Mus musculus and Rattus
norvegicus) and a specific position weight matrix were used to
determine the conservation of the motif across all species.
Cell culture
Human cancer cell lines were originally obtained from ATCC.
MDA-MB-231 cells were maintained in Leibovitz’s L-15 medium
supplemented with 10% fetal calf serum (FCS), 100 mg/ml
penicillin, 100 mg/ml streptomycin and 0.03% L-Glutamine.
These cells were grown at 37uC without CO2 supply.
miRNA repression and overexpression assays
MDA-MB-231 cells were seeded at 200.000 cells per well in 6-
well plates in complete medium without antibiotics one day prior to
transfection. The miRNA precursors and inhibitors as well as the
positive and the negative control miRNAs were transfected at a final
concentration of 25 nM using DharmaFECT 1 transfection reagent
(ThermoSCIENTIFIC- Dharmacon) according to the manufactur-
er’s instructions with the modification of using 8 ml of reagent
instead of 6. The medium was refreshed after 18–24 hrs for the
MDA-MB-231 cells and total RNA was collected 48 hrs post
transfection. The negative control is Pre-miRTM miRNA Precur-
sor–Negative Control#1, which does not target any known mRNA
within the human or mouse transcriptome. The positive control is
miR-1 Pre-miR miRNA precursor which has been shown to
effectively downregulate the expression of twinfilin-1, also known as
PTK9, at the mRNA level [56]. Validation of the downregulation of
PTK9 was performed using a TaqManH Gene Expression Assay
(Assay ID: Hs00702289_s1). The control miRNAs and the qRT-
PCR assay for human PTK9 were provided in the Pre-miRTM
miRNA Starter Kit (Ambion Cat #AM1540).
ZEB1 repression assay
MDA-MB-231 cells were seeded at 200.000 cells per well in 6-
well plates in complete medium without antibiotics one day prior
to transfection. ZEB1 siGENOME-SMARTpool was used for the
downregulation of ZEB1 (ThermoSCIENTIFIC- Dharmacon, M-
006564-02-0010), which consists of four SMART-selection
designed siRNAs targeting one gene. The siZEB1 was dissolved
in 16 siRNA buffer (ThermoSCIENTIFIC- Dharmacon, B-
002000-UB) at a final concentration of 20 mM and was transfected
at a final concentration of 25 nM using DharmaFECT 1
transfection reagent (ThermoSCIENTIFIC- Dharmacon) accord-
ing to the manufacturer’s instructions with the modification of
using 8 ml of reagent instead of 6. As a negative control 16 siRNA
buffer was used (MOCK transfection).
Quantitative reverse transcription PCR (qRT-PCR)
Total RNA was extracted using Trizol (Invitrogen) according to
the manufacturer’s instructions with one modification; absolute
ethanol was used in place of isopropanol. For the qPCR analysis
cDNA synthesis was performed on 1 mg of total RNA using the
iScript synthesis kit (BIO-RAD). The qRT-PCR for every gene
was performed on 20 ng of cDNA in triplicate using the
SYBRGreen I Master (Roche) or Probes Master (Roche) on a
LightCyclerH480 Real-time PCR System (Roche). The expression
levels were determined using comparative quantification to the
negative control and all quantification data were normalized
against 2 reference genes, HMBS and TBP. The sequences of the
RT-qPCR primers that were used are given in the data file S1.
Supporting Information
Table S1 Complete list of module genes and regulators.
Found at: doi:10.1371/journal.pone.0010162.s001 (0.28 MB
XLS)
Table S2 Gene Ontology (GO) categories enrichment for each
module.
Found at: doi:10.1371/journal.pone.0010162.s002 (0.14 MB
XLS)
Data file S1 Gene expression profile of MYH11, CNN1,
ACTG2 and MYLK compared to SRF; TCF12 binding motifs
for module 18 genes; ZEB binding motifs for module 25 genes;
PCR primers.
Found at: doi:10.1371/journal.pone.0010162.s003 (0.49 MB
DOC)
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Figure 4. Module 25 hypothetical regulation model. MiR-200
genes repress ZEB factors, which in turn repress the expression of
module 25 genes. The light yellow indicate genes assigned as
regulators, the light green indicates module genes while the light
orange indicates genes not assigned as regulators, but supported by
literature (indirect regulation). This regulatory model support the
positive correlation of the expression patterns between mir-200a and
module 25 genes.
doi:10.1371/journal.pone.0010162.g004
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